Author

Gary Riordan

Observed name: GARY RIORDAN

Observed institutions: Center for Biologics Evaluation and Research, United States Food and Drug Administration

OpenAlex ID: A5066564795

Abstract PO2-14-09: Baseline genomic alterations and the activity of lasofoxifene (LAS) plus abemaciclib (Abema) in patients with ER+/HER2- metastatic breast cancer (mBC): the ELAINE 2 study

2024 · Senthil Damodaran, Massimo Cristofanilli, et al. · Cancer Research · 1

Abstract P5-05-04: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study

2023 · Matthew P. Goetz, Einav Gal-Yam, et al. · Cancer Research · 1

Abstract P5-05-02: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene plus abemaciclib in the ELAINE 2 study

2023 · Senthil Damodaran, Halle Moore, et al. · Cancer Research

A Rapid, Sensitive, PCR‐Based Method for Detection of HIV‐1 Specific Nucleic Acid in the Culture Supernatant of Infected Cells

1993 · INDIRA K. HEWLETT, BHARAT JOSHI, et al. · Annals of the New York Academy of Sciences

Works count: 4

Citation count: 2

H-index: 1

I10-index: